Financial Architects (New Jersey)’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-3,013
Closed -$161K 1545
2016
Q1
$161K Hold
3,013
0.06% 217
2015
Q4
$340K Sell
3,013
-2,987
-50% -$329K 0.14% 149
2015
Q3
$706K Hold
6,000
0.3% 76
2015
Q2
$465K Hold
6,000
0.17% 111
2015
Q1
$347K Hold
6,000
0.13% 125
2014
Q4
$194K Sell
6,000
-978
-14% -$29.4K 0.08% 172
2014
Q3
$178K Buy
6,978
+978
+16% +$19.9K 0.09% 160
2014
Q2
$106K Buy
+6,000
New +$96.6K 0.05% 219
2013
Q4
Sell
-6,000
Closed -$64K 752
2013
Q3
$64K Hold
6,000
0.04% 225
2013
Q2
$34K Buy
+6,000
New +$36.3K 0.03% 284

Other funds holding ANAC

Financial Architects (New Jersey)'s ANAC Position: Q2 2016 in Review

Financial Architects (New Jersey) sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,013 shares — an estimated $161K sold.

Financial Architects (New Jersey) first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $706K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Financial Architects (New Jersey) reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 3,013 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $161K.
  • Financial Architects (New Jersey) first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
  • Financial Architects (New Jersey)'s ANACOR PHARMACEUTICALS INC COM position peaked at $706K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2016, filed 25 Jul 2016.